Gynecologic Cancer InterGroup (GCIG) Consensus Review for Cervical Adenocarcinoma

被引：38

作者：

Fujiwara, Hiroyuki ^{[1
]}

Yokota, Harushige ^{[2
]}

Monk, Bradley ^{[3
]}

Treilleux, Isabelle ^{[4
]}

Devouassoux-Shisheboran, Mojgan ^{[5
]}

Davis, Alison ^{[6
,7
]}

Kim, Jae-Weon ^{[8
]}

Mahner, Sven ^{[9
]}

Stany, Michael ^{[10
]}

Pignata, Sandro ^{[11
]}

Ray-Coquard, Isabelle ^{[4
]}

Fujiwara, Keiichi ^{[12
]}

机构：

[1] Jichi Med Univ, Shimono City, Japan

[2] Saitama Canc Ctr, Saitama, Japan

[3] Univ Arizona, Phoenix, AZ USA

[4] Ctr Leon Berard, F-69373 Lyon, France

[5] Hosp Civils Lyon, Lyon, France

[6] Canberra Hosp, Canberra, ACT, Australia

[7] ANZGOG, Camperdown, NSW, Australia

[8] Seoul Natl Univ, Coll Med, Seoul, South Korea

[9] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[10] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA

[11] Ist Nazl Tumori Fdn G Pascale IRCCS, Milan, Italy

[12] Saitama Med Univ, Int Med Ctr, Hidaka City, Japan

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期

关键词：

Cervical Cancer; Adenocarcinoma; Pathology; Staging; Clinical management; SQUAMOUS-CELL CARCINOMA; UTERINE CERVIX; ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; RADICAL SURGERY; PHASE-III; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; UNITED-STATES; EARLY-STAGE;

D O I：

10.1097/IGC.0000000000000263

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Cervical adenocarcinoma is known to be less common than squamous cell carcinoma of the cervix comprising approximately 25% of all cervical carcinomas. Differences in associated human papillomavirus types, patterns of spread, and prognosis call for treatments that are not always like those for squamous cancers. In this review, we report a consensus developed by the Gynecologic Cancer InterGroup surrounding cervical adenocarcinoma for epidemiology, pathology, treatment, and unanswered questions. Prospective clinical trials are needed to help develop treatment guidelines.

引用

页码：S96 / S101

页数：6

共 49 条

[1]

[Anonymous], 2014, NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer

[2] Prognostic factors in adenocarcinoma of the uterine cervix [J].